Global Neo-Endorphin Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Neo-Endorphin Market Insights, Forecast to 2034
Global Neo-Endorphin market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Neo-Endorphin industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Neo-endorphin is a new member of the endorphin family about which relatively little is known. According to existing knowledge, Neo-endorphin may be a biochemically synthesized hormone secreted by the pituitary gland, which binds to opioid receptors on the cell surface and regulates the opening and closing of potassium, calcium and other ion channels in the cell membrane. Changes the resting potential of cells, thus exerting effects similar to morphine, including analgesic, euphoria, narrowing pupils, regulating body temperature, etc.
Under stress conditions of the body, such as exercise, painful stimulation, major blows to the body, etc., the release of Neo-endorphins can protect the body. In addition, activities such as jogging and eating spicy food may also promote the release of Neo-endorphins. However, excessive levels of Neo-endorphins may also have adverse health effects, including autism, depression, insomnia, frigidity, etc.
In summary, Neo-endorphin is a new member of endorphins with potential therapeutic applications, and more research is needed to deeply understand its biochemical properties, physiological effects, and pharmacological properties to provide a theory for the development of new therapeutic methods. Base.
Report Covers
This report presents an overview of global Neo-Endorphin market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Neo-Endorphin market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
Segment by Type
α-Neo-Endorphin
β-Neo-Endorphin
Scientific Research
Medical
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Neo-Endorphin plant distribution, commercial date of Neo-Endorphin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Neo-Endorphin introduction, etc. Neo-Endorphin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Neo-Endorphin
Chapter 15Methodology and Data Sources adopted by MRAResearch
Neo-endorphin is a new member of the endorphin family about which relatively little is known. According to existing knowledge, Neo-endorphin may be a biochemically synthesized hormone secreted by the pituitary gland, which binds to opioid receptors on the cell surface and regulates the opening and closing of potassium, calcium and other ion channels in the cell membrane. Changes the resting potential of cells, thus exerting effects similar to morphine, including analgesic, euphoria, narrowing pupils, regulating body temperature, etc.
Under stress conditions of the body, such as exercise, painful stimulation, major blows to the body, etc., the release of Neo-endorphins can protect the body. In addition, activities such as jogging and eating spicy food may also promote the release of Neo-endorphins. However, excessive levels of Neo-endorphins may also have adverse health effects, including autism, depression, insomnia, frigidity, etc.
In summary, Neo-endorphin is a new member of endorphins with potential therapeutic applications, and more research is needed to deeply understand its biochemical properties, physiological effects, and pharmacological properties to provide a theory for the development of new therapeutic methods. Base.
Report Covers
This report presents an overview of global Neo-Endorphin market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Neo-Endorphin market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
Segment by Type
α-Neo-Endorphin
β-Neo-Endorphin
Segment by Application
Scientific Research
Medical
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Neo-Endorphin plant distribution, commercial date of Neo-Endorphin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Neo-Endorphin introduction, etc. Neo-Endorphin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Neo-Endorphin
Chapter 15Methodology and Data Sources adopted by MRAResearch
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices